- Scrip Originals
- Featured Topics
Brought to you by
Shionogi gets botulinum toxin candidate from Tokushima Univ.
19 Dec 2016
Tokushima University licensed Shionogi & Co. Ltd. worldwide rights to develop, manufacture, and promote a Type A2 botulinum toxin candidate.
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com